Browse > Article

Relationship between Systemic Inflammatory Marker, Oxidative Stress and Body Mass Index in Stable COPD Patient  

Ham, Hyun Seok (Department of Internal Medicine, College of Medicine, Gyeongsang National University)
Lee, Hae Young (Department of Internal Medicine, College of Medicine, Gyeongsang National University)
Lee, Seung Jun (Department of Internal Medicine, College of Medicine, Gyeongsang National University)
Cho, Yu Ji (Department of Internal Medicine, College of Medicine, Gyeongsang National University)
Jeong, Yi Young (Department of Internal Medicine, College of Medicine, Gyeongsang National University)
Kim, Ho Cheol (Department of Internal Medicine, College of Medicine, Gyeongsang National University)
Ham, Jong Ryeal (Department of Internal Medicine, College of Medicine, Gyeongsang National University)
Park, Chan Hoo (Department of Pediatrics, College of Medicine, Gyeongsang National University)
Lee, Jong Deok (Department of Internal Medicine, College of Medicine, Gyeongsang National University)
Sohn, Hyun Joon (Department of Anatomy, Medical School of Chungbuk National University)
Youn, Hee Shang (Department of Pediatrics, College of Medicine, Gyeongsang National University)
Hwang, Young Sil (Department of Internal Medicine, College of Medicine, Gyeongsang National University)
Publication Information
Tuberculosis and Respiratory Diseases / v.61, no.4, 2006 , pp. 330-338 More about this Journal
Abstract
Background: The main factors associated with weight loss in patients with COPD are not well known. Since chronic inflammation and oxidative stress play a major pathogenic role in COPD, these factors may be responsible for the patients' weight loss. Therefore, this study measured the body mass index (BMI) in COPD patients and evaluated the variables, such as systemic inflammatory marker, oxidative stress and lung function, that correlate with the BMI. Method: The stable COPD patients (M:F=49:4, mean age=$68.25{\pm}6.32$) were divided into the lower (<18.5), normal (18.5-25) and higher (>25) BMI group. The severity of the airway obstruction was evaluated by measuring the $FEV_1$. The serum IL-6 and TNF-$\alpha$ levels were measured to determine the degree of systemic inflammation, and the carbonyl protein and 8-iso-prostaglandin $F_2{\alpha}$ level was measured to determine the level of oxidative stress. Each value in the COPD patients and normal control was compared with the BMI. Results: 1) Serum 8-iso-prostaglandin $F_2{\alpha}$ in COPD patients was significantly higher ($456.08{\pm}574.12pg/ml$) than that in normal control ($264.74{\pm}143.15pg/ml$) (p<0.05). However, there were no significant differences in the serum IL-6, TNF-$\alpha$, carbonyl protein between the COPD patients and normal controls. 2). In the COPD patients, the $FEV_1$ of the lower BMI group was significantly lower ($0.93{\pm}0.25L$) than that of the normal BMI ($1.34{\pm}0.52L$) and higher BMI groups ($1.72{\pm}0.41L$) (p<0.05). The lower $FEV_1$ was significantly associated with a lower BMI in COPD patients (p=0.002, r=0.42). The BMI of very severe COPD patients was significantly lower ($19.8{\pm}2.57$) than that of the patients with moderate COPD ($22.6{\pm}3.14$) (p<0.05). 3). There were no significant differences in the serum IL-6, TNF-$\alpha$, carbonyl protein and 8-iso-prostaglandin $F_2{\alpha}$ according to the BMI in the COPD patients. Conclusion: The severity of the airway obstruction, not the systemic inflammatory markers and oxidative stress, might be associated with the BMI in stable COPD patients. Further study will be needed to determine the factors associated with the decrease in the BMI of COPD patients.
Keywords
COPD; Oxidative stress; Systemic inflammatory marker; BMI;
Citations & Related Records

Times Cited By SCOPUS : 1
연도 인용수 순위
1 Dolan S, Varkey B. Prognostic factors in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2005:11:149-52   DOI
2 Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, et al. Relationship of interleukin-6 and tumor necrosis factor- with muscle mass and muscle strength in elderly men and women. J Gerontol A Biol Sci Med Sci 2002:57: M326-32   DOI   ScienceOn
3 Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003:329:23-38   DOI
4 Barreiro E, de la Puente B, Minguella J, Corominas JM, Serrano S, Hussain SN, et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005:171:1116-24   DOI   ScienceOn
5 Karadag F, Karul AB, Cildag O, Altun C, Gurgey O. Determinants of BMI in patients with COPD. Respirology 2004:9:70-5   DOI   ScienceOn
6 Couillard A, Prefaut C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J 2005:26:703-19   DOI   ScienceOn
7 PraticoD, Basili S, Vieri M, Cordova C, Violi F, Fitzgerald GA. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F 2a-III, an index of oxidant stress. Am J Respir Crit Care Med 1998:158:1709-14   DOI
8 Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends Mol Med 2003:9:169-76   DOI   ScienceOn
9 Wouters EF. Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005:2:26-33
10 Biernacki WA, Kharitonov SA, Barnes PJ. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003:58:294-8   DOI   ScienceOn
11 Agust AG, Gari PG, Sauleda J, Busquets X. Weight loss in chronic obstructive pulmonary disease: mechanisms and implications. Pulm Pharmacol Ther 2002:15:425-32   DOI   ScienceOn
12 Janssen LJ. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 2001:280:L1067-82
13 Spurzem JR, Rennard SI. Pathogenesis of COPD. Semin Respir Crit Care Med 2005:26:142-53   DOI   ScienceOn
14 de Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM. Elevated TNF-a production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 1996:153:633-7   DOI   ScienceOn
15 Takabatake N, Nakamura H, Abe S, Inoue S, Hino T, Saito H, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor$\alpha$ system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000:161:1179-84   DOI
16 MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005:2:258-66
17 MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005:2:50-60
18 Celli BR, Cote CG, Martin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004:350:1005-12   DOI   ScienceOn
19 di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994:150:1453-5.   DOI   ScienceOn
20 Expert Panel on the Identification, Evaluation and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr 1998:68:899-917   DOI
21 Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl 2003:41:46s-53s
22 Malo O, Sauleda J, Busquets X, Miralles C, Agusti AG, Noguera A. Systemic inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol 2002:38:172- 6   DOI   ScienceOn
23 Global Initiative for Chronic Obstructive Lung Disease. NHLBI/WHO, Workshop report. National Institutes of Health Publication Number 2701, 2001
24 Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003:21:347-60   DOI   ScienceOn
25 Barreiro E, Gea J, Corominas JM, Hussain SN. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2003:29:771-8   DOI   ScienceOn
26 Petrovsky N, Harrison LC. The chronobiology of human cytokine production. Int Rev Immunol 1998; 16:635-49   DOI   ScienceOn
27 Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD; eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993:147:1151-6   DOI   ScienceOn
28 Song W, Zhao Z, Li Z. Interleukin-6 in bronchoalveolar lavage fluid from patients with COPD. Chin Med J 2001:114:1140-2.